49 results
8-K
EX-99.1
CTKB
Cytek BioSciences Inc
8 May 24
Cytek Biosciences Reports First Quarter 2024 Financial Results
4:20pm
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A
8-K
EX-99.1
CTKB
Cytek BioSciences Inc
19 Mar 24
Cytek® Biosciences Names William McCombe Chief Financial Officer
5:00pm
Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934
8-K
EX-99.1
CTKB
Cytek BioSciences Inc
1 Mar 24
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
6:06am
contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities
8-K
EX-99.1
36p305 hl
9 Jan 24
Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
6:05am
8-K
EX-99.1
qgy2cyyj7zed lmaqf
28 Nov 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
3prpqzae
7 Nov 23
Cytek Biosciences Reports Third Quarter 2023 Financial Results
4:45pm
8-K
EX-99.1
govlu6 uypoal27vwjuz
8 Aug 23
Cytek Biosciences Reports Second Quarter 2023 Financial Results
4:17pm
8-K
EX-99.1
iupeofvr w1vc4
9 May 23
Cytek Biosciences Reports First Quarter 2023 Financial Results
4:24pm
8-K
EX-99.1
4wmzscumal1c2hfyvj
9 Nov 22
Cytek Biosciences Reports Third Quarter 2022 Financial Results
4:24pm
8-K
EX-99.1
ps2 3k015
1 Nov 22
Cytek® Biosciences Names Chris Williams Chief Operating Officer
5:16pm
S-3ASR
EX-4.4
hde8lz
26 Aug 22
Automatic shelf registration
5:07pm
S-3ASR
EX-1.2
6ig65rjh dh6i3
26 Aug 22
Automatic shelf registration
5:07pm
S-3ASR
3kk1hn rijidejx2en6
26 Aug 22
Automatic shelf registration
5:07pm